European Journal of Immunology

The European Journal of Immunology (EJI) is an immunology research journal, focusing on various aspects of immunology including, but not limited to:

Established in 1971, the Journal has been serving the needs of the immunology community worldwide with objective enthusiasm. While mechanistic insight, which helps us better understand the workings of the immune system is of great importance for EJI, we are also interested in studies that contain thought-provoking immunological findings. EJI is the official journal of the European Federation of Immunological Societies (EFIS).

Fast review

Our fast review process means you won't be scooped and your results will reach the community rapidly.

• Extra fast review can be requested if you know that there is a competing group about to publish data similar to yours
• EJI's policy of essential, not extensive revisions, means a shorter revision time and faster time to acceptance
• Out-of-scope/low priority manuscripts: Authors are informed within 7 days
• Average time from submission to first decision: 21 days
• Average time from accept to online publication (Accepted Article): 5 days
  


Fair review

Our fair review process means your paper receives the attention that it deserves by immunologists who are experts in the field.

• EJI's Executive Committee are leading immunologists (See EJI Editorial Board).
• Two editors assess every manuscript submitted; if there is any difference of opinion, a third editor's opinion is sought.
• EJI reviewers should only ask for essential, not extensive revisions, and not "nice to have" experiments that don't change the conclusions of the paper; paramount for EJI is that a manuscript details solid, reproducible science that supports the claims being made.
• If an EJI reviewer has been too demanding, you are encouraged to disagree with such requests by addressing this in a point-by-point response providing that solid scientific reasons for why the requested changes are unreasonable are given.
• EJI considers confirmatory studies, including recently scooped papers, providing that the data are solid and use a different approach, thus adding weight to the confirmation.
• EJI considers preliminary studies using only a couple of different approaches rather than a full story provided that the data are interesting and generate insight into a valid, hypothesis-driven question.
• EJI does not require full mechanistic insight but rather significant insight into the field investigated and solid data that support the conclusions drawn.
• EJI publishes the editorial correspondence and reviewers' reports online as Supporting Information 

Clinical studies

EJI's editorial team understands the experimental restrictions of clinical/human studies.

• EJI considers descriptive clinical papers without a mechanism, provided that the studies are hypothesis-driven with a clear rationale and informative results.
• EJI's editorial board features many clinical experts who help assess clinical studies.

• Microbiome: perspective and reviews
• Virtual Issue: Innate Immunity in Host-Pathogen Interactions
• Accepted articles online: articles published online within days after acceptance
• Technical reports: significant improvements on methods of general interest to the immunological community
• Frontline articles: the noteworthy research published with priority
• Regular Reviews and Commentaries place research in a broader context
• Rapid peer review and a fast track option available for authors
• International team of editors
• News and EFIS: promotes the exchange of information within the immunological communities and societies, as well as enhancing public awareness of immunology
• Meetings calendar: regularly updated immunology events, including those sponsored by EFIS-EJI
• Cover gallery

The European Journal of Immunology offers a web-based manuscript submission and peer review system. This service guarantees fast and safe submission of manuscripts and a rapid assessment process.
 

Simple first submission policy

• As of November 2016, authors are no longer required to format their manuscripts as per EJI style (reference formatting, order of sections etc) for first submission; however, authors need to be aware of EJI's requirements for revised manuscripts and to ensure that their manuscripts are in principle compatible with the article types published in EJI (see "Article types" and "General format, length and style".
• Authors have the choice of submitting their original manuscripts either as separate file types per journal requirements, or as a single unformatted submission file. Supported file types for such a file are PDF and Word documents with display figures and supporting information embedded.
  To submit your manuscript online, please create an account for yourself in our Online Submission System (http://mc.manuscriptcentral.com/eurjimmu/), and submit your manuscript following the instructions of the system. If you have any questions concerning online submission, do not hesitate to contact editorial support at ejied@wiley.com
• All papers are assessed initially by the journal's Executive Committee. Authors should indicate two of the journal's Executive Committee Editors whose area of expertise is closest to the topic of the paper.

Writing a manuscript can be a difficult and exacting process. Here a few tips that authors should consider before submitting their manuscript to EJI.
 

• Objectively assess whether the manuscript is suitable for EJI
• Clearly present the novelty, strengths and limitations of the study
• Present the findings clearly and ensure that the manuscript is well-written
• Ensure that a full statistical analysis of the results has been included
• Fully discuss the current literature
• Ensure that the manuscript complies with the format requirements of EJI (see Instructions to Authors for further information on format, style and structure)
• Find more information here: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4141/homepage/ForAuthors.html

Our news feature, "News and EFIS" promotes the exchange of information within the immunological communities and societies, as well as enhancing public awareness of immunology.
 

Call for future "News and EFIS articles"

Do you have items of interest for "News and EFIS"? We welcome suggestions for both topical, themed sections, e.g. women in European immunological research, and more general feature items on subjects relevant to European Research, its implementation, discoveries, development and international impact, as well as international news impacting on Europe and the interplay between the two. Space is limited to a maximum of four pages per issue for this section so individual feature items should be concise (approximately 2500 words and 3-4 Figures; shorter articles are also of interest). Images to accompany items are welcomed. All suggestions should be e-mailed to ejied@wiley.com for consideration.

5.4 (2022)